Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication November 19, 2013
- Accepted for publication March 3, 2014
- Published online July 1, 2014.
Article Versions
- previous version (May 12, 2014 - 05:20).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- Bruce E. Hillner1,
- Barry A. Siegel2,
- Lucy Hanna3,
- Fenghai Duan3,
- Anthony F. Shields4,
- Bruce Quinn5 and
- R. Edward Coleman†,6
- 1Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia
- 2Division of Nuclear Medicine, Mallinckrodt Institute of Radiology and the Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
- 3Departments of Biostatistics and Center for Statistical Sciences, Brown University, Providence, Rhode Island
- 4Karmanos Cancer Institute, Wayne State University, Detroit, Michigan
- 5Foley Hoag LLC, Boston, Massachusetts; and
- 6Department of Radiology, Duke University School of Medicine, Durham, North Carolina
- For correspondence or reprints contact: Bruce E. Hillner, Virginia Commonwealth University, 1101 East Marshall St., Rm. 7013 (Sanger Hall), Richmond, VA 23298-0170. E-mail: Hillner{at}vcu.edu
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Whole-Skeleton SUVmean Measured on 18F-NaF PET/CT Studies as a Prognostic Indicator in Patients with Breast Cancer Metastatic to Bone
- Molecular Imaging of Bone Metastases and Their Response to Therapy
- Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
- 18F-Sodium Fluoride PET: History, Technical Feasibility, Mechanism of Action, Normal Biodistribution, and Diagnostic Performance in Bone Metastasis Detection Compared with Other Imaging Modalities
- Intended Versus Inferred Treatment After 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
- The Injustice of Being Judged by the Errors of Others: The Tragic Tale of the Battle for PET Reimbursement
- Hospice Admission and Survival After 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
- Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment
- 18F-Fluoride PET in the Assessment of Malignant Bone Disease
- 18F-Fluoride PET Used for Treatment Monitoring of Systemic Cancer Therapy: Results from the National Oncologic PET Registry